A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/11990245

Download in:

View as

General Info

PMID
11990245